Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : INCY source : Www.globenewswire.com save search
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Published: 2024-04-01 (Crawled : 12:30) - globenewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: -0.58%
license collaboration asia agreement china
Knight Therapeutics Announces Launch of Minjuvi® in Brazil
Published: 2024-02-29 (Crawled : 12:30) - globenewswire.com
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 2.68%
H: 2.22%
C: -1.92%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -3.07%
minjuvi brazil therapeutics
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.6%
H: 0.45%
C: 0.08%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 2.3%
H: 0.58%
C: -2.69%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -3.07%
business year update financial results
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
Published: 2023-11-02 (Crawled : 20:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 3.51%
H: 9.56%
C: 9.56%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.52%
H: 1.38%
C: 1.11%
business update financial results
Knight Therapeutics Announces CMED Price Approval of Minjuvi® (tafasitamab) in Brazil
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.0%
H: 1.49%
C: 0.53%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.62%
H: 0.16%
C: -0.59%
minjuvi approval brazil therapeutics
Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil
Published: 2023-10-10 (Crawled : 21:00) - globenewswire.com
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 0.05%
H: 3.15%
C: -2.53%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.45%
H: 0.52%
C: -0.94%
brazil therapeutics submission
Merus Announces Financial Results for the Second Quarter 2023 and Provides Business Update
Published: 2023-08-07 (Crawled : 21:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 11.43%
H: 6.32%
C: 3.08%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 3.79%
H: 1.72%
C: -11.69%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 2.58%
H: 0.41%
C: -1.13%
business update financial results
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
Published: 2023-06-12 (Crawled : 20:00) - globenewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.48%
H: 1.44%
C: 0.24%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: -0.92%
H: 1.29%
C: 0.55%
Zai Lab Announces First Quarter 2023 Financial Results and Corporate Updates
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.21%
H: 0.32%
C: -0.07%
ZLAB | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: 4.89%
H: 6.5%
C: 1.13%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.17%
H: 0.07%
C: -0.17%
NVCR | $12.09 0.33% 0.33% 850K
|
Health Technology
|
| O: 1.11%
H: 1.89%
C: 0.97%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: -2.41%
H: 5.41%
C: 3.75%
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 1.07%
H: 1.21%
C: 0.62%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.29%
H: 0.07%
C: -1.6%
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: 1.36%
H: 0.13%
C: -1.89%
results
Merus Announces Financial Results for the First Quarter 2023 and Provides Business Update
Published: 2023-05-04 (Crawled : 20:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.08%
H: 0.74%
C: -0.07%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 4.36%
H: 8.41%
C: 5.96%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.85%
H: 1.46%
C: -0.28%
business update financial results
Merus Announces Financial Results for the Fourth Quarter and Full Year 2022 and Provides Business Update
Published: 2023-02-28 (Crawled : 23:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.39%
H: 2.23%
C: 1.35%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 4.04%
H: 1.21%
C: -1.92%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.04%
H: 1.31%
C: 1.06%
year financial update
Merus Announces Financial Results for the Third Quarter and Provides Business Update
Published: 2022-11-03 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.25%
H: 2.48%
C: 2.15%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: -38.62%
H: 31.1%
C: 22.14%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.86%
H: 1.31%
C: 0.54%
financial update
Knight Therapeutics Announces Regulatory Submission for Tafasitamab in Brazil
Published: 2022-10-06 (Crawled : 23:00) - globenewswire.com
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: -1.92%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -2.18%
H: 0.2%
C: -2.02%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.72%
H: 0.38%
C: -1.04%
brazil therapeutics submission
MacroGenics Announces Closure of CP-MGA271-06 Study Evaluating Enoblituzumab plus Checkpoint Inhibition in Head and Neck Cancer
Published: 2022-07-08 (Crawled : 21:00) - globenewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
| Email alert
Add to watchlist
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
| Email alert
Add to watchlist
mga271 plus cancer study
Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update
Published: 2022-02-28 (Crawled : 22:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 1.03%
H: 4.76%
C: 0.35%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.44%
H: 2.1%
C: 0.88%
financial results ces results
Annual Changes to the Nasdaq-100 Index®
Published: 2021-12-11 (Crawled : 04:20) - globenewswire.com
FOX | News | $28.87 2.05% 2.01% 1.1M
|
Consumer Services
| Email alert
Add to watchlist
LCID | $2.44 0.0% 15M
|
| Email alert
Add to watchlist
NDAQ | $60.35 0.47% 0.46% 3.1M
|
Finance
| Email alert
Add to watchlist
CDW | $235.75 0.02% 0.02% 590K
|
Technology Services
| Email alert
Add to watchlist
FTNT M | $63.42 -0.95% -0.96% 4.8M
|
Electronic Technology
| Email alert
Add to watchlist
CHKP | News | $157.9 -0.3% -0.3% 670K
|
Technology Services
| Email alert
Add to watchlist
PANW | $277.8 -1.19% -1.2% 4.7M
|
Electronic Technology
| Email alert
Add to watchlist
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
| Email alert
Add to watchlist
DDOG | $120.1 -3.94% -4.1% 3.6M
|
Technology Services
| Email alert
Add to watchlist
CERN | $94.92 0.03%
|
Technology Services
| Email alert
Add to watchlist
ZS | $169.23 -2.16% -2.21% 2.3M
|
Technology Services
| Email alert
Add to watchlist
ABNB | $155.0 -3.19% -3.29% 3.9M
|
Administrative and Support and ...
| Email alert
Add to watchlist
TCOM | $48.0 -1.48% -1.5% 2.2M
|
Consumer Services
| Email alert
Add to watchlist
FOXA | News | $31.38 1.98% 1.94% 2.3M
|
Consumer Services
| Email alert
Add to watchlist
index nasdaq
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -0.89%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.06%
H: 0.28%
C: 0.18%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
ema car-t platform
Merus Announces Regulatory Update on Zenocutuzumab, Financial Results for the Third Quarter and Provides Business Update
Published: 2021-11-02 (Crawled : 21:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 2.72%
H: 0.0%
C: 0.0%
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: 1.64%
H: 6.45%
C: 2.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: 0.0%
financial results results
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Incyte for Tafasitamab and Pemigatinib in Latin America
Published: 2021-09-23 (Crawled : 12:00) - globenewswire.com
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -1.27%
H: 4.26%
C: 4.17%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 1.56%
H: 1.29%
C: 0.97%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.52%
H: 1.43%
C: 0.79%
distribution
MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuximab in Combination with Retifanlimab in Gastroesophageal Adenocarcinoma at ESMO 2021
Published: 2021-09-16 (Crawled : 07:00) - globenewswire.com
MGNX | $15.62 -2.8% -2.88% 1M
|
Health Technology
|
| O: -2.29%
H: 0.0%
C: -21.97%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.69%
H: 2.94%
C: 2.89%
phase 2 phase 2/3 results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.